Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.
Patients at local physician clinics as well as my own clinic will be enrolled at the time they are evaluated for having COVID-19. Patients enrollment will be voluntary and based upon their request for treatment with Ivermectin. These patients will be questioned on symptoms and the timing of those symptoms in detail. They will then be followed throughout their treatment course to evaluate their recovery experience. Detailed accounts of their symptoms and their resolution will be followed. The study patients will stop being followed when they are either admitted to the hospital or are deemed to be symptom free. Any other medications prescribed to the patients will also be tracked. Medical histories will be taken and documented to make comparisons at the end of the study. Those patients not requesting Ivermectin will also be followed for comparisons at a later date.
Study Type
OBSERVATIONAL
Enrollment
1,000
Ivermectin treatment of outpatients dosing at 0.4mg/kg until recovered along with supplemental treatment using a multi-modal approach.
Patrick Robinson MD LLC
San Antonio, Florida, United States
RECRUITINGComplete recovery from COVID-19 with resolution of symptoms
This group recovered completely from COVID-19 and remained an outpatient throughout the duration of their illness.
Time frame: 4-6 weeks per individual
Admission to a hospital for further advanced treatment
This group of patients was unable to recover at home and required hospital admission
Time frame: 4-6 weeks per individual
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.